TY - JOUR
T1 - Low levels of alcohol consumption, obesity and development of fatty liver with and without evidence of advanced fibrosis
AU - Chang, Yoosoo
AU - Ryu, Seungho
AU - Kim, Yejin
AU - Cho, Yong-Kyun
AU - Sung, Eunju
AU - Kim, Han-na
AU - Ahn, Jiin
AU - Jung, Hyun-Suk
AU - Yun, Kyung Eun
AU - Kim, Seolhye
AU - Sung, Ki-Chul
AU - Sohn, Chong Il
AU - Shin, Hocheol
AU - Wild, Sarah
AU - Byrne, Christopher D
PY - 2020/3/22
Y1 - 2020/3/22
N2 - The effects of low level alcohol consumption on fatty liver disease and the potential for effect modification by obesity is uncertain. We investigated associations between low level alcohol consumption, obesity status and the development of incident hepatic steatosis (HS) either with or without, an increase in noninvasive liver fibrosis score category (from low to intermediate or high category). A total of 190,048 adults without HS and a low probability of fibrosis with alcohol consumption <30g/day (men) and <20g/day (women) were followed for up to 15.7 years. Alcohol categories of no, light and moderate consumption were defined as 0, 1-9.9, and 10-29.9 g/day (10-19.9 g/day for women), respectively. HS was diagnosed by ultrasonography, and the probability of fibrosis was estimated using the fibrosis-4 index (FIB-4). Parametric proportional hazards models were used to estimate multivariable-adjusted hazard ratios (aHR) and 95% confidence intervals (CI). 43,466 participants developed HS. 2,983 participants developed HS with an increase in FIB-4 index (to intermediate or high scores). Comparing light-drinkers and moderate-drinkers with non-drinkers, aHR (95% CI) for incident HS were 0.93 (0.90-0.95) and 0.90 (0.87-0.92), respectively; in contrast, comparing light-drinkers and moderate-drinkers with non-drinkers, aHR (95% CI) for developing HS plus intermediate/high FIB-4 were 1.15 (1.04-1.27) and 1.49 (1.33-1.66), respectively. The association between alcohol consumption categories and incident HS plus intermediate/high FIB-4 was observed in both non-obese and obese individuals although the association was stronger in non-obese individuals (p for interaction by obesity=0.017). CONCLUSION: Light/moderate alcohol consumption has differential effects on the development of different stages of fatty liver disease which is modified by the presence of obesity. This article is protected by copyright. All rights reserved.
AB - The effects of low level alcohol consumption on fatty liver disease and the potential for effect modification by obesity is uncertain. We investigated associations between low level alcohol consumption, obesity status and the development of incident hepatic steatosis (HS) either with or without, an increase in noninvasive liver fibrosis score category (from low to intermediate or high category). A total of 190,048 adults without HS and a low probability of fibrosis with alcohol consumption <30g/day (men) and <20g/day (women) were followed for up to 15.7 years. Alcohol categories of no, light and moderate consumption were defined as 0, 1-9.9, and 10-29.9 g/day (10-19.9 g/day for women), respectively. HS was diagnosed by ultrasonography, and the probability of fibrosis was estimated using the fibrosis-4 index (FIB-4). Parametric proportional hazards models were used to estimate multivariable-adjusted hazard ratios (aHR) and 95% confidence intervals (CI). 43,466 participants developed HS. 2,983 participants developed HS with an increase in FIB-4 index (to intermediate or high scores). Comparing light-drinkers and moderate-drinkers with non-drinkers, aHR (95% CI) for incident HS were 0.93 (0.90-0.95) and 0.90 (0.87-0.92), respectively; in contrast, comparing light-drinkers and moderate-drinkers with non-drinkers, aHR (95% CI) for developing HS plus intermediate/high FIB-4 were 1.15 (1.04-1.27) and 1.49 (1.33-1.66), respectively. The association between alcohol consumption categories and incident HS plus intermediate/high FIB-4 was observed in both non-obese and obese individuals although the association was stronger in non-obese individuals (p for interaction by obesity=0.017). CONCLUSION: Light/moderate alcohol consumption has differential effects on the development of different stages of fatty liver disease which is modified by the presence of obesity. This article is protected by copyright. All rights reserved.
U2 - 10.1002/hep.30867
DO - 10.1002/hep.30867
M3 - Article
SN - 1527-3350
VL - 71
SP - 861
EP - 873
JO - Hepatology
JF - Hepatology
IS - 3
ER -